Jin, Gui-Hua <br/><br/>
Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.  [electronic resource] 

 -  International immunology  Jun 2008 
 - 783-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2377 
<br/><br/><label>Standard No.: </label>10.1093/intimm/dxn036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Genetically Modified<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Dendritic Cells--drug effects<br/>G(M1) Ganglioside--immunology<br/>Heparin-binding EGF-like Growth Factor<br/>Immunity, Cellular<br/>Immunotherapy<br/>Intercellular Signaling Peptides and Proteins--genetics<br/>Interleukin-2--antagonists & inhibitors<br/>Killer Cells, Natural--drug effects<br/>Lung Neoplasms--immunology<br/>Melanoma, Experimental--immunology<br/>Mice<br/>Neoplasm Metastasis<br/>Neoplasm Transplantation